HTG Announces Major Sales Milestone for HTG Transcriptome Panel

Recognizes More Than $1 Million of HTP Revenue Through November 2021 TUCSON, Ariz. , Dec. 09, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced